ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
FlexShs Morningstar Dvlp Mkt ex US Factor Tilt Index Fund

FlexShs Morningstar Dvlp Mkt ex US Factor Tilt Index Fund (TLTD)

71.1347
0.035
(0.05%)
Closed November 03 4:00PM
71.13
-0.0047
(-0.01%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
71.1347
Bid
-
Ask
-
Volume
2,278
71.13 Day's Range 71.54
60.57 52 Week Range 75.5401
Market Cap
Previous Close
71.0997
Open
71.44
Last Trade
100
@
71.1347
Last Trade Time
Financial Volume
$ 162,616
VWAP
71.3856
Average Volume (3m)
9,672
Shares Outstanding
7,800,000
Dividend Yield
-
PE Ratio
9.11
Earnings Per Share (EPS)
7.81
Revenue
17.78M
Net Profit
60.91M

About FlexShs Morningstar Dvlp Mkt ex US Factor Tilt Index Fund

The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Morningstar Emerging Markets Factor Tilt IndexSM. The index reflects the performance of a selection of companies that, in aggregate, possess greater exposure to size... The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Morningstar Emerging Markets Factor Tilt IndexSM. The index reflects the performance of a selection of companies that, in aggregate, possess greater exposure to size and value factors relative to the Morningstar Developed Markets ex-US Index, a float-adjusted market-capitalization weighted index of companies incorporated in developed-market countries, excluding the U.S. The fund will invest at least 80% of its total assets in the securities of the index and in ADRs and GDRs based on the securities in the index. Show more

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
Lutherville Timonium, Maryland, USA
Founded
-
FlexShs Morningstar Dvlp Mkt ex US Factor Tilt Index Fund is listed in the Unit Inv Tr, Closed-end Mgmt sector of the American Stock Exchange with ticker TLTD. The last closing price for FlexShs Morningstar Dvlp... was $71.10. Over the last year, FlexShs Morningstar Dvlp... shares have traded in a share price range of $ 60.57 to $ 75.5401.

FlexShs Morningstar Dvlp... currently has 7,800,000 shares outstanding. The market capitalization of FlexShs Morningstar Dvlp... is $554.58 million. FlexShs Morningstar Dvlp... has a price to earnings ratio (PE ratio) of 9.11.

TLTD Latest News

State Street Debuts Unique Momentum and Value ETFs - ETF News And Commentary

Over the years, State Street has built itself into a major ETF power with nearly a quarter trillion dollars in AUM. The company has over 100 different offerings in its lineup, including the...

FlexShares Debuts Two International ETFs - ETF News And Commentary

Northern Trust continues to expand its ETF lineup under its ‘FlexShares’ brand and for good reason given how popular its four most recent ETFs have been. These products have already...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.8653-1.201805555567272.0770.61442071.54337835SP
4-2.6653-3.6115176151873.874.187470.61565672.73791914SP
122.19473.1834928923768.9475.540168.94967273.10931364SP
261.44472.0730377385669.6975.540166.571409572.24379994SP
5210.564717.442133069260.5775.540160.571396270.20367488SP
156-3.0053-4.0535473428674.1475.540150.41878864.85103971SP
2608.214713.05578512462.9276.2440.322641259.77542279SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VSTEVast Renewable Ltd
$ 4.98
(149.00%)
68.46M
INVZWInnoviz Technologies Ltd
$ 0.096
(96.71%)
22.71k
CDXCChromaDex Corporation
$ 5.87
(68.19%)
37.58M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
236.07M
TILEInterface Inc
$ 23.24
(33.03%)
2.12M
EPIXESSA Pharma Inc
$ 1.45
(-72.12%)
33.85M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
201.61M
OSTOstin Technology Group Company Ltd
$ 0.275
(-45.00%)
2.27M
LXRXLexicon Pharmaceuticals Inc
$ 1.23
(-36.92%)
19.96M
VCIGVCI Global Ltd
$ 0.0583
(-27.58%)
26.13M
ATHAAthira Pharma Inc
$ 0.606
(41.56%)
236.07M
SQQQProShares UltraPro Short QQQ
$ 7.44
(-2.11%)
214.96M
NVDANVIDIA Corporation
$ 135.40
(1.99%)
206.38M
ELABElevai Labs Inc
$ 0.0288
(-51.19%)
201.61M
INTCIntel Corporation
$ 23.20
(7.81%)
171.4M

Discussion

View Full Feed
bb8675309 bb8675309 3 minutes ago
Power - Your not the only investor who thinks the SP / MC is undervalued.

"Does anyone think/know if MM are keeping lid on SP to allow buddies to close short position at these lower prices"?

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avxl/anavex-life
AVXL
Monksdream Monksdream 3 minutes ago
SRCL, new 52+week low
https://investorshub.advfn.com/uimage/uploads/2024/11/3/dvvzvIMG_2967.gif
SRCL
zab zab 3 minutes ago
https://www.bbc.com/news/articles/c5y398q2kq4o

Watching women voters are overwhelmingly voting for Kamala Harris.
theorysuit theorysuit 4 minutes ago
I told you that was a warning sign. And that footnote was BS too...trying to make it look like a RSU tax sell
NWBO
pos_stock_hoarder pos_stock_hoarder 4 minutes ago
Damn those lying eyes!

https://assets.amuniversal.com/6bba2a305c55013d70ed005056a9545d
Poor Man - Poor Man - 5 minutes ago
Yup, that’s another point. Before BP or institutional investors are likely to join in (and maybe even to just quality for an uplist ) the governance and management issues will need to be addressed. There’s a lot of clean up work that needs to happen.
NWBO
theorysuit theorysuit 7 minutes ago
How about never look back....too much drama and nonsense in this ticker. That was a hell of a wise decision to lighten the load.
NWBO
BDEZ BDEZ 7 minutes ago
Love that one....
Wolf-man jack Wolf-man jack 7 minutes ago
Message in reply to:
WQLF ASKS; Is Daiwa Pharmaceutical interested in partnering with CV Sciences Lunar Fox 🦊 Wholly Owned Subsidiary? Have Mercy Have Faith Have Patience Have International Partners Have International M&A’s WQLF Ahooooooo

DAIWA PHARMACEUTICAL CO.,LTD.
CVSI
DanM51 DanM51 7 minutes ago
Matt, you are way off! Adagium put out a simple post saying Investment Advocates bought 300,000 shares of lwlg as a new position. It was the frequent poster/moderator that pumped it up almost immediately as a managed fund buy. Nobody knows, but with 700+ positions, I'd say the odds are in Ted's fav
LWLG
Monksdream Monksdream 8 minutes ago
ARGX new 52+week high
https://investorshub.advfn.com/uimage/uploads/2024/11/3/vttzuIMG_2966.gif
ARGX
BDEZ BDEZ 8 minutes ago
@Texit..thanks Bob, been following that for awhile, another of my former residences....loved it there.
Farmboynate Farmboynate 8 minutes ago
Queen of Dilution and Reverse splits... still waiting for her to make good on promises but I think the piece of paper cert I have around 10.5 million shares on paper is only good tp..... If' Id invested in bitcoin around .01 instead of this pos I'd of made 23 billion dollars.....
PPJE
zab zab 8 minutes ago
https://www.9news.com/article/news/politics/elections/des-moines-register-mediacom-iowa-ann-selzer-poll-trump-harris-presidential-election/524-afc84985-394c-4aca-b4cc-af6878569798

Feeling better today, when I was in college, and yes Drake University was my college for four years, the
delerious1 delerious1 8 minutes ago
I remember hearing about an OTC runner back in 2021 and realized that I had missed it and wasn't going to chase it.....some must have chased it and others held too long.....some made some good money playing it....from .0005 to $1.93 in 3 months ....and it didn't have 2 Gold Mines and 55% of a Mill
NBRI
Monterey2000 Monterey2000 9 minutes ago
IDCC Q3 free cash flow for Q3 2024 was reported as $65 million on page 4 in the presentation slides. Also on page 4, IDCC raised midpoint of FY 2024 revenue guidance by $145 million to $860 million.

IMHO, The additional recurring revenue from the OPPO license, Samsung arbitration o
IDCC
exwannabe exwannabe 9 minutes ago
If a new trial was needed, it would have been pointed out in the Journal, no doubt.
Why? The paper, like most, never said anything about approval. There have been many, many very positive papers published in JAMA and other comparable journals that said nothing on the subject yet further tria
NWBO
BDEZ BDEZ 10 minutes ago
Thanks for that gms...
jimr1717 jimr1717 10 minutes ago
Dec 36th 2093 soon
NFTM
BDEZ BDEZ 11 minutes ago
election day..tuesday
pos_stock_hoarder pos_stock_hoarder 11 minutes ago
It's the Demarhoid way!

https://assets.amuniversal.com/1c66eb607a2b013d79e9005056a9545d